Login / Signup

Evolution of Breast Cancer Recurrence Risk Prediction: A Systematic Review of Statistical and Machine Learning-Based Models.

Hasna El HajiAmine SouadkaBhavik N PatelNada SbihiGokul RamasamyBhavika K PatelMounir GhoghoImon Banerjee
Published in: JCO clinical cancer informatics (2023)
ML-based prediction models exhibit outstanding performance, yet their practical applicability might be hindered by limited interpretability and reduced generalization. Moreover, predictive models for BC recurrence often focus on limited variables related to tumor, treatment, molecular, and clinical features. Imbalanced classes and the lack of open-source data sets impede model development and validation. Furthermore, existing models predominantly overlook African and Middle Eastern populations, as they are trained and validated mainly on Caucasian and Asian patients.
Keyphrases
  • machine learning
  • end stage renal disease
  • newly diagnosed
  • big data
  • south africa
  • patient reported outcomes
  • african american
  • single molecule
  • combination therapy
  • breast cancer risk